Dr Kim RM Blenman
Dr Blenman is an Assistant Professor of Medicine in the Yale School of Medicine, Department of Internal Medicine, Section of Medical Oncology, and the Yale Cancer Center. Dr Blenman is also an Assistant Professor of Computer Science in the Yale School of Engineering and Applied Science, Department of Computer Science. She earned a bachelor's in chemistry, a master's in clinical chemistry, and a doctorate in immunology from the University of Florida, Gainesville, Florida. Her research at that time focused on the autoimmune disease Systemic Lupus Erythematosus. She also has a certificate in Drug Development and Regulatory Sciences from the University of California San Francisco. She had the privilege of learning and working on drug discovery and clinical development at Procter & Gamble's Pharmaceutical division as a senior scientist and as a global research director for the autoimmune diseases Inflammatory Bowel Disease and Irritable Bowel Syndrome. She re-entered academia as a traditional Postdoctoral Fellow at the City of Hope Comprehensive Cancer Center in Duarte, California. During her fellowship, she uncovered a potential use for B cells in predicting metastasis and disease-free survival in breast cancer patients and pursed her passion of computer science. Dr Blenman’s current interest is in clinical research, software development, therapeutic development, and health disparities. Her disease focus areas are cancer and autoimmunity with a special interest in the therapy-induced toxicity (treatment emergent adverse events (TEAEs)) bridge between the two disease areas.